phase 3 study

phase 3 study

See Phase study.
References in periodicals archive ?
The company said, "Phase 2 Study for Oral PTH in osteoporosis: The overall design and registration requirements for the planned pivotal Phase 3 study have been largely defined following the input from the U.S.
M2 PHARMA-March 25, 2019-Moberg Pharma announces completion of enrolment of patients for MOB-015 phase 3 study in Europe
M2 EQUITYBITES-March 25, 2019-Moberg Pharma announces completion of enrolment of patients for MOB-015 phase 3 study in Europe
Global Banking News-March 25, 2019-Moberg Pharma announces completion of enrolment of patients for MOB-015 phase 3 study in Europe
A pivotal Phase 3 study is planned for 2018 evaluating the use of dupilumab in eosinophilic esophagitis (EoE), a condition for which there are no approved therapies in the U.S.
We are delighted to formally engage with a CRO of the caliber and reputation of PRA to run this Phase 3 study of a treatment for a cancer indication in which there is an utmost medical need in the eyes of oncologists and the FDA."
Accentia proposes to move forward with its first phase 3 study on recurrent post-surgical chronic sinusitis patients, and would like to include in its confirmatory phase 3 study additional patients who suffer from moderate to severe chronic sinusitis but have not had surgery, in order to seek an expanded label indication when the drug launches.
If all goes well, an investigational drug will end up in a phase 3 study where several hundred people receive it for 6 months or longer.
Based on positive interactions at these meetings, the companies are now planning a pivotal European Phase 3 study involving general surgery patients undergoing various procedures.
The submission was supported by previously disclosed positive results of two global Phase 3 studies in people with cystic fibrosis, or CF: a 24-week Phase 3 study in people with one F508del mutation and one minimal function mutation and a 4-week Phase 3 study in people with two F508del mutations.
M2 EQUITYBITES-March 25, 2019-BioArctic announces initiation of confirmatory phase 3 study of BAN2401 in early Alzheimer's disease by its partner Eisai
Global Banking News-March 25, 2019-BioArctic announces initiation of confirmatory phase 3 study of BAN2401 in early Alzheimer's disease by its partner Eisai